Press Releases
Press Releases
-
Rezolute Presents RZ358 Clinical Data-Validated Model of the Pharmacokinetics and Glycemic Response in Congenital Hyperinsulinism at Pediatric Endocrine Society 2020 Annual Meeting
-
Rezolute to Present Clinical Data for RZ358, Lead Candidate in Phase 2b Trial in Congenital Hyperinsulinism at Virtual Pediatric Endocrine Society 2020 Annual Meeting
-
Rezolute, Inc. Announces Updates to Clinical and Business Operations in Response to COVID-19 Pandemic
-
Rezolute Initiates Phase 2b Clinical Trial of Lead Candidate RZ358 in Congenital Hyperinsulinism
-
Rezolute to Present at BIO CEO & Investor Conference 2020
-
Rezolute, Inc. Announces Top-line Results from Phase 1 Trial Evaluating AB101 in Patients with Diabetes
-
Rezolute Management to Present at 2020 Biotech Showcase Conference
-
Rezolute Appoints Nektar Therapeutics COO & CFO to Its Board of Directors
-
Rezolute Management to Present at 2019 BIO Investor Forum Conference
-
Rezolute Management to Present at 2019 Canaccord Genuity Growth Conference